IGF1-LR3

IGF-1 LR3

Overview

IGF-1 LR3 is a synthetic research protein derived from human insulin-like growth factor 1 (IGF-1), studied in laboratory settings for its interaction with regulatory pathways related to cellular growth, differentiation, and protein signaling.

Within controlled research environments, IGF-1 LR3 has been observed for its potential influence on receptor activity, peptide stability, and signaling processes associated with cellular development and metabolic research at the cellular level.

Scientific Background

IGF-1 LR3 is an 83-amino-acid analog designed to enhance stability and bioactivity compared to endogenous IGF-1. Its structure contains an arginine substitution at the third amino-acid position and a 13-amino-acid extension at the N-terminus.

In vitro studies focus on its interaction with the insulin-like growth factor 1 receptor (IGF-1R) and downstream signaling pathways. Research explores IGF-1 LR3’s structural properties, receptor-binding activity, reduced interaction with IGF-binding proteins, and its role in modulating cellular signaling under controlled laboratory conditions.

Specifications

• Molecular Formula: C400H625N111O115S9
• Sequence Length: 83 amino acids
• Molecular Weight: Approximately 9.1 kDa
• Purity: ≥99%
• Form: Lyophilized powder
• Storage: -20°C
• Solubility: Sterile water or bacteriostatic water

Disclaimer

For laboratory research use only. Not for human consumption, medical, or veterinary use.

Bourbon Peptides — Research Grade Purity.